Patients with chronic heart failure (BIOSTAT-CHF) with elevated levels of IGFBP7 showed a 44% (HR = 1.44 [CI 1.23–1.70], p < 0.001) increase in combined adverse endpoints156. The gene discussed is IGFBP7; the disease is congestive heart failure.